Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.780
-0.220 (-4.40%)
May 15, 2026, 4:00 PM EDT - Market closed
Bolt Biotherapeutics Employees
Bolt Biotherapeutics had 23 employees as of December 31, 2025. The number of employees decreased by 29 or -55.77% compared to the previous year.
Employees
23
Change
-29
Growth
-55.77%
Revenue / Employee
$282,565
Profits / Employee
-$1,286,087
Market Cap
9.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 23 | -29 | -55.77% |
| Sep 30, 2025 | 40 | -12 | -23.08% |
| Dec 31, 2024 | 52 | -48 | -48.00% |
| Dec 31, 2023 | 100 | 6 | 6.38% |
| Dec 31, 2022 | 94 | 3 | 3.30% |
| Dec 31, 2021 | 91 | 26 | 40.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 36 |
| PMGC Holdings | 34 |
| Lunai Bioworks | 29 |
| Imunon | 25 |
| Genprex | 13 |
| BioVie | 13 |
| NuCana | 12 |
| CDT Equity | 4 |
BOLT News
- 5 days ago - Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Bolt Biotherapeutics reports Q4 EPS ($3.84), consensus ($5.52) - TheFly
- 2 months ago - Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Bolt Biotherapeutics to Participate in Upcoming March Conferences - GlobeNewsWire
- 6 months ago - Bolt Biotherapeutics reports Q3 EPS ($3.72), consensus ($5.39) - TheFly
- 6 months ago - Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 months ago - Bolt Biotherapeutics assumed with a Buy at H.C. Wainwright - TheFly
- 8 months ago - Bolt Biotherapeutics to reduce workforce by 50%, gives update on BDC-4182 study - TheFly